March 20 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO :
* Aralez Pharmaceuticals- Adrian Adams, CEO, acquired additional 500,000 shares of company's common stock on March 15, 2017 in open-market purchases
* Aralez Pharmaceuticals - shares were purchased at an average price of $2.46 per share, for an aggregate purchase price of approximately $1.2 million
* Adams now owns about 3.6 million shares of company's common stock Source text for Eikon: ID:nPn1lph0Ka Further company coverage: ARZ.TO